RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 10/16/26
Followers: 439
Posts Today: 0
Views Today: 1420

CYDY Stock Quote & Tools

$0.2283 ▲ +0.0229 (+11.14%) As of Oct 16, 3:59 PM EDT
Last0.2283
$ Chg0.0229
Open0.2050
High0.2300
Beta1.4964
Year High0.397
Market Cap335.42M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.68M
Volume3.96M
% Chg+11.14%
Prev Close0.2054
Low0.2050
VWAP0.21542
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. ohm20

    Yet another reason to use leronlimab for COVID-19. dormant cancer cells (DCCs). DCCs

    (10)
  2. MarcS

    Then show us the PR as none of the rest of us remember any such thing.

  3. PTM1

    I may be mistaken, but I thought there was an announcement by the CRO that the first Brazil

  4. jeff67

    I have consistently heard from management they "hoped" the first injection for Brazil l would be in

    (1)
  5. Hulk767

    and we don't have connections politically. that's just further proof to me of how crooked the

    (8)
  6. MarcS

    Article: Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug: The FDA

    (4)
  7. Cycl2R

    New Proactive https://www.youtube.com/watch?v=Mjhn_jx1akA&t=113s

  8. ohm20

    The difference between Biogen and Cytodyn is that we don't have $13 billion in revenue...

    (7)
  9. Evil Rabbit

    If your boss refuses to give you a raise, do you get aggressive? Probably smarter to look for

    (12)
  10. Figgs

    Every time I suggest that NP get aggressive with the FDA, get all of these dislikes. Who are these

  11. Dvb

    See new Dr Drew interview of Dr Patterson and Dr Yo. See at 1:10:10 for mention of LL

    (2)
  12. MarcS

    There needs to be a housecleaning at the FDA from top to bottom. Massive firings on the order of

    (8)
  13. KenChowder

    Here at I Hang we have rigorous editorial standards. Several copy editors are employed fulltime

    (3)
  14. Figgs

    You are right, I thought that last ProActive video he said the Brazil trials start in a few days or

  15. gestalt2

    I think we decided on "going at it alone" because we were/are "alone". I don't think it was a

    (5)
  16. mtruong34

    Why would you think the Brazil trial has already started when they just released a PR a couple of

    (8)
  17. sean007

    Leronlimab mentioned no less than 122 times in 10 pages...ABBvie employee, Incelldx employee,

    (3)
  18. Figgs

    Watched the proactive video. The Brazil trial "will hopefully be starting very soon..." WTF I

    (5)
  19. ohm20

    when the drug is shown to have an effect on a surrogate endpoint that is reasonably likely

    (8)
  20. MicMac

    I'm seeing lots of tweets by docs and others in response to the FDA news. Not at all

    (2)
  21. HCIT

    What a travesty, now BiiB is up 57% as the price rises over 167.00 a share just today's gain and

    (3)
  22. smurph

    "The trials were terminated in March 2019 when a futility analysis determined aducanumab was

  23. Figgs

    I wonder if our "go it alone" approach for so many years now is the right way. I really would like

  24. Fumbler

    A Tweet in response to FDA's approval of Aduhelm.... Bob Herman @bobjherman 9m Jaw on the

    (3)
  25. gestalt2

    Now I know what we are doing wrong, we should have gotten doctors to say Leronlimab does NOT work.

    (7)
  26. Evil Rabbit

    ...the F.D.A. granted approval on the condition that the manufacturer, Biogen, conduct a new

    (7)
  27. Fumbler

    Well, isn't this a kick in the nuts....from the NY Times. "The Food and Drug Administration on

    (8)
  28. Figgs

    The FDA appears to be approving every MAB, every drug it can to block

    (2)
  29. dfwl28

    "Dr. Ndhlovu receives an annual stock option as a member of CytoDyns Scientific Advisory Board.

    (1)
  30. ohm20

    Have never seen the movie but have read all about Oliver Sacks and his experiments with L-Dopa and

    (3)
  31. ohm20

    Proactive video - https://www.youtube.com/watch

    (8)
  32. Goosebumps

    All I can think of is Robin Williams and Robert Deniro in the movie Awakenings. It wasnt about

    (5)
  33. ohm20

    It certainly looks like yet again a favor to BP from the FDA. One thing we can say about

    (5)
  34. HCIT

    Good point, we'll have to just see this play out. The Prep news just came out so will take time to

    (1)
  35. FBCoach18

    Now this blows my mind. FDA approves the first new drug for Alzheimers in

    (2)
  36. WUM

    PTM, I was thinking the same thing! Two of our advisors were involved. I almost said finally! Maybe

    (4)
  37. Kevin0461

    SP will rise when we get some solid results or substantial revenue, whichever comes

    (2)
  38. JLang

    When you announce you've got the next best thing to an HIV vaccine and the stock is down a few

    (2)
  39. PTM1

    I guess now we know a little more about the CYDY scientific advisory board.

    (2)
  40. HCIT

    Yes KenChowder, the manipulators do not care as they are told to keep an incessant hammer lock on

    (8)
  41. ohm20

    Led in part to two cases of a cure of HIV? Dr. Ndhlovu was talking about the

    (6)
  42. mountaineer

    Every blind squirrel finds an acorn occasionally :)

    (2)
  43. mountaineer

    And yet I bought some more :)

    (2)
  44. Goosebumps

    Did anyone catch the wording about cure? Led in part to two cases of a cure of HIV? I

    (2)
  45. KenChowder

    -- Guess what? We can prevent Hiv, and maybe cure it too. -- How dare you! You go down four

    (4)
  46. WUM

    Wow, its nature! Great! Will bring world wide attention!

    (2)
  47. Enjay

    Looks like long haulers can apply for the Phase 3 trial in Gainesville, however, enrollment is not

    (3)
  48. mountaineer

    Great idea ! :)

  49. LaundryMoney

    From my perspective, I've never received a thumbs down. I just turn my phone or PC upside down and

    (3)
  50. mountaineer

    wonder who gave you thumbs down. Apparently someone I have or been blocked

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Exploring the Explosive Growth of the Blockchain Market by 2030

Updated Category News Views 54

Looking Ahead: Blockchain Market Growth Predictions The blockchain market is on an impressive growth path, expected to reach an astonishing $403.36 billion by 2030. This surge highlights the growing need for secure and transparent transaction methods. The primary drivers behind this expansion include increasing demands in the Banking, Financial Services, and Insurance...

Continue Reading
Capri Holdings Investors: Class Action Lawsuit Insights

Updated Category News Views 180

Capri Holdings Class Action Lawsuit Overview Right now, an important class action lawsuit is taking shape that involves Capri Holdings Limited (NYSE: CPRI). Investors who believe they have suffered losses exceeding $50,000 are encouraged to engage and learn about their options. The lawsuit is spearheaded by Faruqi & Faruqi, LLP, a dedicated national securities law firm...

Continue Reading
Until Labs Secures $58 Million in Series A Funding for Innovation

Updated Category News Views 294

Until Labs Secures $58 Million in Series A Funding Until Labs has announced a significant advancement in medical technology by securing a $58 million Series A funding round. This funding, led by Founders Fund with contributions from Lux Capital and Field Ventures, is aimed at enhancing their innovative solutions for organ transplantation. What is Until Labs Working On?...

Continue Reading
Sogeclair Delivers Impressive Financial Outcomes for 2024

Updated Category News Views 122

Sogeclair's Financial Performance Overview for 2024 Sogeclair has recently reported its financial results for 2024, showcasing a strong performance that exceeds expectations. The company has established itself as a notable player in the aerospace and transportation sectors, characterized by its innovative solutions and dedication to quality. These results reflect...

Continue Reading
TTM Technologies Reports Strong Q3 Performance and Outlook

Updated Category News Views 345

TTM Technologies Achieves Strong Growth in Q3 Recently, the investment firm Needham made headlines by raising its price target for TTM Technologies (NASDAQ: TTMI) from $24 to $26. This upgrade reflects the company's impressive performance in the third quarter, particularly highlighting its substantial margins and revenue growth. Key Growth Drivers In the third quarter,...

Continue Reading